All-Cause Mortality and Gastrointestinal Adverse Effects in Adults With Type 2 Diabetes on Glucagon-Like Peptide-1 Receptor Agonists vs Sodium-Glucose Cotransporter-2 Inhibitors.

Saved in:
Bibliographic Details
Title: All-Cause Mortality and Gastrointestinal Adverse Effects in Adults With Type 2 Diabetes on Glucagon-Like Peptide-1 Receptor Agonists vs Sodium-Glucose Cotransporter-2 Inhibitors.
Authors: Garg S; Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio., Qapaja T; Department of Hospital Medicine, Washington University in St. Louis, St. Louis, Missouri., Hamid O; Department of Gastroenterology, University of Texas Southwestern, Dallas, Texas., Kaya G; Department of Hospital Medicine, Washington University in St. Louis, St. Louis, Missouri., Abdel-Razeq R; Department of Internal Medicine, Fairview Hospital, Cleveland, Ohio., Alayan D; Department of Pulmonary and Critical Care, MetroHealth Medical Center, Cleveland, Ohio., Abu-Rumaileh M; Department of Internal Medicine, University of Toledo, Toledo, Ohio., Lembo A; Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio., Nissen S; Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Source: Gastro hep advances [Gastro Hep Adv] 2025 Jul 05; Vol. 4 (10), pp. 100736. Date of Electronic Publication: 2025 Jul 05 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc on behalf of the AGA Institute Country of Publication: Netherlands NLM ID: 9918350485906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-5723 (Electronic) Linking ISSN: 27725723 NLM ISO Abbreviation: Gastro Hep Adv Subsets: In Process
Database: MEDLINE Ultimate
Description
ISSN:2772-5723
DOI:10.1016/j.gastha.2025.100736